These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1798830)

  • 1. Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin.
    Sills TL; Vaccarino FJ
    Psychopharmacology (Berl); 1991; 105(3):329-34. PubMed ID: 1798830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual differences in the feeding effects of amphetamine: role of nucleus accumbens dopamine and circadian factors.
    Sills TL; Baird JP; Vaccarino FJ
    Psychopharmacology (Berl); 1993; 112(2-3):211-8. PubMed ID: 7871022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual differences in sugar consumption following systemic or intraaccumbens administration of low doses of amphetamine in nondeprived rats.
    Sills TL; Vaccarino FJ
    Pharmacol Biochem Behav; 1996 Aug; 54(4):665-70. PubMed ID: 8853187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
    Weiss F; Tanzer DJ; Ettenberg A
    Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission.
    Hurd YL; Lindefors N; Brodin E; Brené S; Persson H; Ungerstedt U; Hökfelt T
    Brain Res; 1992 Apr; 578(1-2):317-26. PubMed ID: 1354999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
    Shilling PD; Feifel D; Kelsoe JR
    Neurosci Lett; 2000 Mar; 281(1):17-20. PubMed ID: 10686405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms.
    Evans KR; Vaccarino FJ
    Neurosci Biobehav Rev; 1990; 14(1):9-22. PubMed ID: 2325945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
    Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and nucleus accumbens dopamine in the male Syrian hamster.
    Triemstra JL; Sato SM; Wood RI
    Psychoneuroendocrinology; 2008 Apr; 33(3):386-94. PubMed ID: 18249072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.
    Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC
    J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control.
    Pattij T; Janssen MC; Vanderschuren LJ; Schoffelmeer AN; van Gaalen MM
    Psychopharmacology (Berl); 2007 Apr; 191(3):587-98. PubMed ID: 16972104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism.
    Helm KA; Rada P; Hoebel BG
    Brain Res; 2003 Feb; 963(1-2):290-7. PubMed ID: 12560135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T; Ikeda M; Matsubara K; Matsushita A
    Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior.
    Baldo BA; Kelley AE
    Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1232-42. PubMed ID: 11557632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cholecystokinin potentiate dopamine action in the nucleus accumbens?
    Wang RY; Hu XT
    Brain Res; 1986 Aug; 380(2):363-7. PubMed ID: 3756487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens.
    Sills TL; Crawley JN
    Eur J Pharmacol; 1996 May; 303(3):177-81. PubMed ID: 8813564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.